[1]
W. Yang, X. Wang, H. Yang, and D. Hao, “Impact of PCSK9 Inhibitors on Bone Disease: A Comprehensive Drug-target Mendelian Randomization Study”, JCMP, vol. 7, no. 5, pp. 54–63, May 2025.